Private Trust Company’s AtriCure ATRC Stock Holding History

Private Trust Company’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-152	Closed	-$4.62K	–	2270
2024 Q1	$4.62K	Sell	152 -115	-43%	-$3.85K	﹤0.01%	1951
2023 Q4	$9.53K	Sell	267 -66	-20%	-$2.46K	﹤0.01%	1671
2023 Q3	$14.6K	Buy	333 +20	+6%	+$976	﹤0.01%	1462
2023 Q2	$15.4K	Sell	313 -5	-2%	-$230	﹤0.01%	1458
2023 Q1	$13.2K	Hold	318	–	–	﹤0.01%	1473
2022 Q4	$14K	Buy	318 +2	+0.6%	+$84	﹤0.01%	1426
2022 Q3	$12K	Buy	316 +15	+5%	+$686	﹤0.01%	1371
2022 Q2	$12K	Buy	+301	New	+$14.3K	﹤0.01%	1407

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Private Trust Company's ATRC Position: Q2 2024 in Review

Private Trust Company sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 152 shares — an estimated $4.62K sold.

Private Trust Company first reported a position in ATRC in Q2 2022 and held it in 8 quarters. The position peaked at $15.4K in Q2 2023. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.

Private Trust Company reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
Private Trust Company sold 152 AtriCure shares in Q2 2024, an estimated $4.62K.
Private Trust Company first reported a position in AtriCure in Q2 2022 and held it in 8 quarters.
Private Trust Company's AtriCure position peaked at $15.4K in Q2 2023.
197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.

Based on Private Trust Company's 13F filing for Q2 2024, filed 23 Jul 2024.